The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with the consolidated financial
statements and the related notes included in Part II, Item 8 of this Annual
Report on Form 10-K for the fiscal year ended December 31, 2021. The results of
operations and other information included herein are not necessarily indicative
of the financial condition, results of operations and cash flows that may be
expected in future periods. This Annual Report on Form 10-K, including matters
discussed in this Item 7. "Management's Discussion and Analysis of Financial
Condition and Results of Operations" contains forward-looking statements
relating to our plans, estimates and beliefs that involve important risks and
uncertainties. See "Cautionary Statements Regarding Forward-Looking Information"
and Item 1A. "Risk Factors" for a discussion of uncertainties and assumptions
that may cause actual results to differ materially from those expressed or
implied in the forward-looking statements. Additionally, we use certain non-GAAP
financial measures to evaluate our results of operations, financial condition
and liquidity. For important information regarding the use of such non-GAAP
measures, including reconciliations to the most comparable GAAP measure, see the
section titled "Non-GAAP Financial Measures" below.

This section of this Annual Report on Form 10-K generally
discusses 2021 and 2020 items and year-to-year comparisons between 2021 and
2020. Discussions of 2019 items and year-to-year comparisons
between 2020 and 2019 that are not included in this Annual Report on Form 10-K
can be found in "Management's Discussion and Analysis of Financial Condition and
Results of Operations" in Part II, Item 7 of our Annual Report on Form 10-K for
the fiscal year ended December 31, 2020.

The financial condition and results of operations discussed in this Management's
Discussion and Analysis of Financial Condition and Results of Operations are
those of Welbilt, Inc. and its consolidated subsidiaries, collectively, the
"Company," "Welbilt," "we," "our" or "us."

Overview

Business Overview



We design, manufacture and supply best-in-class equipment for the global
commercial foodservice market with our suite of products capable of storing,
cooking, holding, displaying, dispensing and serving in both hot and cold
foodservice categories. Our portfolio of products is used by commercial and
institutional foodservice operators including full-service restaurants,
quick-service restaurant chains, hotels, resorts, cruise ships, caterers,
supermarkets, convenience stores, hospitals, schools and other institutions. Our
products, product-based services and aftermarket parts and service support are
recognized by our customers and channel partners for their quality, reliability
and durability which support our end customers by improving menus, enhancing
operations and reducing costs.

We manage our business in three geographic business segments: Americas, EMEA and
APAC. The Americas segment includes the United States ("U.S."), Canada and Latin
America. The EMEA segment consists of markets in Europe, including Middle East,
Russia, Africa and the Commonwealth of Independent States. The APAC segment
consists primarily of markets in China, India, Australia, South Korea,
Singapore, Philippines, Japan, Indonesia, Malaysia, Thailand, Hong Kong, Taiwan,
New Zealand and Vietnam. We are required to prepare and present our consolidated
financial statements in accordance with accounting principles generally accepted
in the U.S. ("U.S. GAAP" or "GAAP"). These geographic business segments
represent the level at which separate financial information is available and
which is used by management to assess operating performance and allocate
resources. We evaluate our segment performance based upon Adjusted Operating
EBITDA (a non-GAAP measure). See the definition of Adjusted Operating EBITDA and
other non-GAAP measures used by management within the section titled "Non-GAAP
Financial Measures" of this Management's Discussion and Analysis of Financial
Condition and Results of Operations. In addition, see Note 20, "Business
Segments", of the Notes to the Consolidated Financial Statements included in
Part II, Item 8 of this Annual Report on Form 10-K for further discussion of our
geographic business segments.

Executive Summary

Merger with Ali Holding S.r.l.



On July 14, 2021,Welbilt and Ali Holding S.r.l. ("Ali Group"), a significant and
diversified global foodservice equipment manufacturer and distributor, entered
into a merger agreement under which Ali Group will acquire the Company in an
all-cash transaction for $24.00 per share, or approximately $3.5 billion in
aggregate equity value and $4.8 billion in enterprise value. The merger
agreement was unanimously approved by the Company's board of directors and on
September 30, 2021, was approved by our stockholders.

In accordance with the terms of the merger agreement and immediately prior to the merger:



(i)   all of the Company's outstanding and unvested common stock options and
restricted stock units will become vested and exchanged for the right to receive
cash equal to the $24.00 per share consideration (less the exercise price per
share of common stock for the common stock options), and

(ii) all of the Company's outstanding performance share units will also be exchanged, as determined assuming the maximum level of performance is achieved, for the right to receive cash equal to the $24.00 per share consideration,

Upon completion of the transaction, the Company's shares will no longer trade on The New York Stock Exchange.


                                      -36-
--------------------------------------------------------------------------------

The Ali Group merger agreement provides that the Company may be required to pay
Ali Group a termination fee equal to $110.0 million if the merger agreement is
terminated:

(a) by Ali Group due to a breach of a covenant or agreement by the Company that causes the failure of a condition to closing, or



(b)   by either party if the Merger has not been consummated prior to July 14,
2022 (subject to extension if certain approvals have not been obtained by such
date) or

if, in the case of clauses (a) or (b), an alternative proposal has been publicly
disclosed, announced or otherwise made public and has not been withdrawn and
within twelve months of such termination our company enters into a definitive
agreement with respect to, or consummates, an alternative proposal.

Welbilt and Ali Group have submitted regulatory filings in all required jurisdictions, including the U.S., United Kingdom, and European Union. The companies have decided that they will proceed with divesting the Ice Divestiture and the companies are confident that this step will ensure regulatory approval.



In October 2021, the Company's board of directors concluded that outside
consultants should be authorized to commence a process that could result in the
sale of the Ice business. Our outside consultants, with the assistance of
management, have initiated the marketing and due diligence process for the Ice
divestiture. The companies expect to complete Ice Divestiture in the first half
of 2022 with the acquisition of Welbilt by Ali Group to close shortly
thereafter.

As of December 31, 2021, we concluded that the Ice business does not meet the criteria to be classified as an asset held for sale or its operations to be classified as discontinued operations in accordance with the applicable accounting literature.

Financial Results Highlights

Highlights of our financial results as of and for the year ended December 31, 2021 as compared to our financial results as of and for the year ended December 31, 2020 include the following:

•Net sales were $1,546.9 million, an increase of 34.1%.

•Organic net sales (a non-GAAP measure) were $1,521.7 million, an increase of 31.9%.

•Gross profit (as a percentage of net sales) was 36.2% compared to 35.5% for the year ended December 31, 2020.

•Earnings from operations were $181.6 million, an increase of 187.8%.



•Adjusted Operating EBITDA (a non-GAAP measure) was $275.4 million, an increase
of 61.1%, while Adjusted Operating EBITDA margin (a non-GAAP measure) was 17.8%,
compared to 14.8% in 2020.

•Net earnings were $70.3 million and Adjusted Net Earnings (a non-GAAP measure) was $98.5 million.



•Diluted net income per share was $0.49 and Adjusted Diluted Net Earnings Per
Share (a non-GAAP measure) was $0.69 as of December 31, 2021. Comparatively,
diluted net loss per share was (0.05) and Adjusted Diluted Net Earnings Per
Share (a non-GAAP measure) was $0.16 as of December 31, 2020.

•As of December 31, 2021, our total liquidity was $407.6 million, consisting of
$134.2 million of cash and cash equivalents and $273.4 million available for
additional borrowing under the senior secured revolving credit facility, to the
extent we are compliant with financial covenants that permit such borrowings.
This compares to liquidity of $375.0 million as of December 31, 2020.

•Our total outstanding long-term debt, excluding finance leases, as of December 31, 2021, was $1,400.0 million.



The following is a summary of factors that impacted our operating results and
liquidity during the year ended December 31, 2021 and other notable actions we
have taken during the year:

Impact of COVID-19 Pandemic on our Business



Global economic conditions are expected to continue to be volatile as long as
the COVID-19 pandemic remains a public health threat. The ongoing COVID-19
pandemic has resulted in governments around the world implementing stringent
measures to help control the spread of the virus and emergence of new strains of
the virus, including quarantines, "shelter in place" and "stay at home" orders,
curfews, travel restrictions, border closures, limitations on public gatherings,
vaccination mandates, social distancing measures and mandated business
limitations and closures. These measures have resulted in a disruption in the
foodservice industry, including substantial restaurant closures and, as a
result, in commercial foodservice equipment markets across the geographies in
which we operate. We expect global economic performance and the performance of
our businesses to vary by geography and discipline until the impact of the
COVID-19 pandemic on the global economy subsides.
                                      -37-
--------------------------------------------------------------------------------


Our 2021 net sales, earnings from operations and cash flows all improved
significantly in comparison to 2020. While the commercial foodservice industry
has continued to recover from the immediate impacts of the COVID-19 pandemic,
the extent of the ultimate impact of the pandemic, including supply chain
disturbances and shipping and logistics delays, on our operational and financial
performance will depend significantly on future developments, including the
duration, scope and severity of the pandemic, the actions taken to contain,
mitigate or recover from its impact in each of the countries where we operate
globally (including actions taken to ease supply chain backlogs), the
vaccination rates and efficacy, emergence of new strains of the virus, and the
timing of the resumption of economic activity to pre-pandemic levels.

Throughout the year ended December 31, 2021, we continued to see increases in
the cost of specific commodities, components and parts purchased as compared to
the prior year, including the impact of rising inflation rates and tariffs, as
challenges in the supply chain and shipping and logistics delays continue to
persist. The availability of key electronic components used in embedded
electronic controls worsened in 2021, and we expended significant effort and
resources to redesign controls to utilize available parts and to source these
electronic components on the spot market, often at a large premium to historical
prices.

The Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was enacted
in March 2020 and includes measures intended to assist companies during the
COVID-19 pandemic, including temporary changes to income and non-income-based
tax laws, some of which had been enacted under the Tax Cuts and Jobs Act ("Tax
Act") in 2017. As a result of the Tax Act and the CARES Act, additional
legislative and regulatory guidance has been and may continue to be issued,
including final regulations that could impact our effective tax rate in future
periods.

The Consolidated Appropriations Act of 2021 and the American Rescue Plan Act of
2021 extended eligibility for the employee retention tax credit for qualified
wages paid from January 1, 2021, through December 31, 2021. We were not eligible
for this incentive during the year ended December 31, 2021.

On November 5th, 2021, the Occupational Safety and Health Administration
announced an emergency temporary standard mandating the COVID-19 vaccine or
weekly testing for most U.S. employees, which includes our employees. That
standard was struck down by the U.S. Supreme Court on January 13, 2022. However,
the Biden Administration has indicated that it may seek to impose alternative
vaccine mandates and other governmental authorities have imposed more targeted
vaccine and testing orders and regulations, and may continue to do so in the
future. If a mandate is ultimately issued and implemented in some form, we
expect there would be further disruptions to our operations, such as inability
to maintain adequate staffing at our facilities, difficulties in replacing
disqualified employees with temporary employees or new hires, increased costs
and diminished availability of raw materials and component parts, and increased
compliance burdens, including financial costs, diversion of administrative
resources, and increased downtimes to accommodate for any required ongoing
COVID-19 testing, which would result in delays in the manufacturing process,
negatively impact our future sales levels and ongoing customer relationships.

We continue to proactively monitor the developments surrounding COVID-19 and may
take additional actions based on the requirements and recommendations of
governmental and health authorities around the world in an attempt to protect
our stakeholders. Although we are currently unable to quantify with certainty
the ultimate severity or duration of the impact of the global COVID-19 pandemic
on our business, we expect that the challenges in the supply chain and shipping
and logistics delays will likely have a continued impact on our operating
results and financial condition in fiscal 2022.

Business Transformation Program Update



Our Business Transformation Program ("Transformation Program") focuses on
specific areas of opportunity including strategic sourcing, manufacturing
facility workflow redesign, distribution and administrative process efficiencies
and optimizing our global brand platforms. We executed the final phases of the
Transformation Program during the quarter ended December 31, 2021, as originally
planned.

In connection with the execution of the Transformation Program, we incurred $4.6
million of consulting and other related Transformation Program costs for the
year ended December 31, 2021. We also incurred $1.4 million of restructuring
charges for the year ended December 31, 2021, intended to reduce future
operating expenses as a result of the improved efficiencies gained from the
execution of the Transformation Program. We have incurred total costs of $73.4
million from the inception of the Transformation Program through December 31,
2021 and have settled these costs primarily in cash.

Industry and Business Conditions



Through 2020 and 2021, the COVID-19 pandemic created a decline in economic
activity across the globe and many hospitality and restaurant companies were
forced to close either temporarily or permanently, and the vast majority have
experienced a significant decline in revenues. The effects on businesses across
many industries was pervasive and has injected uncertainty into the consumer
foodservice industry. Full-service restaurants continue the trend as being the
most negatively impacted by COVID-19 with limited-service restaurants (which
includes QSR and fast casual restaurants) impacted the least. Many economic
forecasts continue to show the Consumer Foodservice industries sales will not
return to 2019 levels until 2023, maintaining the 3-year recovery period to
reach pre-pandemic 2019 sales.

                                      -38-
--------------------------------------------------------------------------------

Business Strategies



While our strategic objectives are long-term and remain intact, the uncertainty
surrounding the ongoing COVID-19 pandemic will impact the extent and timing of
the execution of these objectives. Our immediate focus remains on ensuring the
safety of our stakeholders and the balancing of our Transformation Program and
innovation investments with the pace of recovery in our revenues as the industry
rebounds. Our specific strategic objectives, which are discussed in further
detail in Part I, Item 1 of this Annual Report on Form 10-K, include:

•  Achieve profitable growth

•  Create innovative products and solutions

•  Enhance customer satisfaction

•  Drive operational excellence

•  Develop great people

Results of Operations for the Years Ended December 31, 2021 and 2020

The following table sets forth our consolidated financial results for the periods presented:



                                                         Years Ended December 31,                          Change
(in millions, except percentage data)                     2021                 2020                $                  %
Net sales                                           $    1,546.9           $ 1,153.4          $  393.5                 34.1  %
Cost of sales                                              987.3               743.4             243.9                 32.8  %
Gross profit                                               559.6               410.0             149.6                 36.5  %
Gross margin (% of Net sales)                               36.2   %            35.5  %
Selling, general and administrative expenses               337.6               285.3              52.3                 18.3  %
Amortization expense                                        39.4                39.1               0.3                  0.8  %

Restructuring and other expense                              0.6                10.9             (10.3)               (94.5) %
Loss from impairment and disposal of assets -
net                                                          0.4                11.6             (11.2)               (96.6) %
Earnings from operations                                   181.6                63.1             118.5                187.8  %
Interest expense                                            74.9                81.4              (6.5)                (8.0) %

Other expense (income) - net                                 7.5                (4.6)             12.1                263.0  %
Earnings (loss) before income taxes                         99.2               (13.7)            112.9                824.1  %
Income tax expense (benefit)                                28.9                (6.3)             35.2                558.7  %
Net earnings (loss)                                 $       70.3           $    (7.4)         $   77.7              1,050.0  %



Analysis of Net Sales



"Net sales" for our geographic business segments consist of the following for
the periods presented:

                                                           Years Ended December 31,                           Change
(in millions, except percentage data)                      2021                    2020                $                  %
Americas                                           $     1,185.8               $   867.0          $  318.8                36.8  %
EMEA                                                       447.1                   292.6             154.5                52.8  %
APAC                                                       261.1                   202.1              59.0                29.2  %
Elimination of intersegment sales                         (347.1)                 (208.3)           (138.8)               66.6  %
Total net sales                                    $     1,546.9               $ 1,153.4          $  393.5                34.1  %



Net sales totaled $1,546.9 million for the year ended December 31, 2021
representing an increase of $393.5 million, or 34.1%, compared to the prior
year. The increase in net sales was primarily the result of: (i) increased
volumes largely due to an increase in general market demand, (ii) increased
volumes due to rollouts with large chain customers and (iii) increased
KitchenCare aftermarket sales, all of which were the result of our continued
recovery from the COVID-19 pandemic, and to a much lesser extent, increased net
pricing. Foreign currency translation positively impacted net sales for the year
ended December 31, 2021 by $25.2 million.

                                      -39-
--------------------------------------------------------------------------------

Net sales in the Americas segment for the year ended December 31, 2021 increased
by $318.8 million, or 36.8%, compared to the prior year. The increase was
primarily driven by increased third-party net sales of $274.9 million and a
$43.9 million increase in intersegment sales. The increase in third-party net
sales was primarily the result of: (i) increased volumes primarily due to an
increase in general market demand, (ii) increased volumes due to rollouts with
large chain customers and (iii) increased KitchenCare aftermarket sales, all of
which were the result of our continued recovery from the COVID-19 pandemic in
the region, and to a much lesser extent, increased net pricing. Foreign currency
translation negatively impacted third-party net sales for the year ended
December 31, 2021 by $7.1 million.

Net sales in the EMEA segment for the year ended December 31, 2021 increased by
$154.5 million, or 52.8%, compared to the prior year. The increase was primarily
the result of increased third-party net sales of $81.7 million and a $72.8
million increase in intersegment sales. The increase in third-party net sales
was primarily the result of increased volumes in the general market and the
increase in intersegment sales was primarily due to increases in sales to the
America's region related to rollouts with large chain customers discussed above,
both of which were the result of our continued recovery from the ongoing
COVID-19 pandemic. Foreign currency translation positively impacted third-party
net sales for the year ended December 31, 2021 by $13.4 million.

Net sales in the APAC segment for the year ended December 31, 2021 increased by
$59.0 million, or 29.2%, compared to the prior year. The increase was primarily
the result of increased third-party net sales of $36.9 million and a $22.1
million increase in intersegment sales. The increase in third-party net sales
was primarily driven by increased volumes in the general market and increased
KitchenCare aftermarket sales, both of which were the result of our continued
recovery from the COVID-19 pandemic. Foreign currency translation positively
impacted third-party net sales for the year ended December 31, 2021 by $4.7
million.

Analysis of Earnings from Operations

Gross profit



"Gross profit" for the year ended December 31, 2021 totaled $559.6 million, an
increase of $149.6 million, or 36.5%, compared to the prior year. This increase
was primarily driven by: (i) a $130.6 million favorable impact from increased
product volumes and mix, (ii) a $29.2 million favorable impact from increased
net pricing, (iii) $15.5 million of positive foreign currency translation impact
and (iv) $14.0 million of favorable labor and other manufacturing costs,
primarily due to improved operating efficiencies related to higher volumes and
equipment investments in our plants associated with the Transformation Program.
These favorable impacts were partially offset by: (i) $19.2 million of increased
inbound freight costs resulting from both higher volumes and the continued
macroeconomic impacts of the COVID-19 pandemic on the supply chain, (ii) $14.0
million of unfavorable material costs, resulting from broad-based inflation
along with the continued macroeconomic impacts of the COVID-19 pandemic on the
supply chain, partially offset by the procurement sourcing savings associated
with the Transformation Program, (iii) a $4.7 million unfavorable impact from
increased tariffs and (iv) $1.6 million of higher depreciation costs.

We expect that the challenges in the supply chain and shipping and logistics
delays will likely have a continued impact, which could possibly be material, on
our gross profit throughout fiscal 2022. The availability of key electronic
components used in embedded electronic controls, for example, worsened in 2021,
and we expended significant effort and resources to redesign controls to utilize
available parts and to source these electronic components on the spot market,
often at a large premium to historical prices. We expect these challenges to
continue. If a COVID-19 vaccine or weekly testing mandate were to be imposed on
our manufacturing labor force, this could also impact ability to maintain
adequate staffing at our facilities, make it difficult to replace disqualified
employees with temporary employees or new hires, and increase costs and
compliance burden, which could materially adversely affect our gross profit
going forward.

Selling, general and administrative expenses



"Selling, general and administrative expenses" for the year ended December 31,
2021 were $337.6 million, an increase of $52.3 million, or 18.3%, compared to
the prior year. This increase is primarily driven by: (i) $29.5 million of
increased employee-related costs, reflecting the non-recurrence of government
subsidies and other measures taken in 2020 to manage the impact of the COVID-19
pandemic, along with higher incentives related to stronger operational
performance in 2021, (ii) $26.4 million of increased transaction expenses
related to the pending sale of our company, (iii) $9.7 million of higher
marketing and commission costs, primarily attributable to increased sales
volumes, (iv) a $5.2 million unfavorable foreign currency translation impact as
compared to the same period of the prior year and (v) $4.4 million of higher
travel and other controllable costs. The impact of these increases was partially
offset by: (i) $18.5 million of lower third-party consulting costs incurred in
connection with our Transformation Program, (ii) $3.2 million of lower
professional fees and (iii) a $2.0 million recovery of funds from an incident in
2018, involving one of our EMEA locations.

Restructuring and other expense



"Restructuring and other expense" for the year ended December 31, 2021 was $0.6
million primarily as a result of a restructuring plan initiated during the first
quarter of 2021 for the consolidation of a manufacturing facility in EMEA.

Restructuring and other expense for the year ended December 31, 2020 was $10.9
million consisting of $7.8 million of severance and related costs and a $3.1
million loss contingency charge. The severance and related costs were associated
with workforce reductions executed throughout 2020 in the Americas and Corporate
regions and a limited management restructuring enabled by the Transformation
Program, as well as 2019 actions completed, and 2020 actions initiated in the
EMEA and APAC regions. The loss contingency charge was associated with our
voluntary review of certain errors in declarations to the U.S. Customs and
Border Protection for customs duties, fees and interest owed for previously
imported products. See Note 11, "Contingencies and Significant Estimates" for
further information.

                                      -40-
--------------------------------------------------------------------------------

Analysis of Segment Adjusted Operating EBITDA

"Adjusted Operating EBITDA" (a non-GAAP measure) for our geographic business segments consists of the following for the periods presented:



                                                       Years Ended December 31,                        Change
(in millions, except percentage data)                   2021                2020                $                  %
Americas                                           $     219.7           $  155.5          $   64.2                41.3  %
EMEA                                                      86.7               46.2              40.5                87.7  %
APAC                                                      40.7               31.2               9.5                30.4  %
Total Segment Adjusted Operating EBITDA                  347.1              232.9             114.2                49.0  %
Less: Corporate and unallocated expenses                 (71.7)             (62.0)             (9.7)              (15.6) %
Total Adjusted Operating EBITDA                    $     275.4           $  170.9          $  104.5                61.1  %

Adjusted Operating EBITDA margin (1)                      17.8   %           14.8  %                                3.0  %


(1) Adjusted Operating EBITDA margin is calculated by dividing the dollar amount of Adjusted Operating EBITDA by net sales.




Adjusted Operating EBITDA in the Americas segment for the year ended December
31, 2021 increased by $64.2 million, or 41.3%. This increase was primarily
driven by: (i) $74.8 million of favorable product volumes and mix, (ii) $33.4
million of favorable impact from net pricing, (iii) $8.2 million of favorable
labor and other manufacturing costs, primarily due to improved operating
efficiencies related to higher volumes and equipment investments in our plants
associated with the Transformation Program, slightly offset by continued
inflationary pressures experienced during the year ended December 31, 2021, (iv)
$3.9 million of favorable foreign currency translation impact and (v) $0.4
million of lower research and development costs. The impact of these increases
was partially offset by: (i) $15.4 million of higher employee-related expenses,
including higher incentives resulting from improved operating results in 2021,
(ii) $14.6 million of unfavorable inbound freight costs resulting from both
higher volumes and the continued on the supply chain challenges, (iii) $12.1
million of higher materials costs, primarily driven by continued inflationary
pressures experienced during the year ended December 31, 2021, slightly offset
by the procurement sourcing savings associated with the Transformation Program,
(iv) $9.6 of higher marketing and commissions costs attributable primarily to
increased sales, (v) $4.1 million of increased tariffs and (vi) $1.0 million of
lower professional fees.

Adjusted Operating EBITDA in the EMEA segment for the year ended December 31,
2021 increased by $40.5 million, or 87.7%. This increase was primarily driven
by: (i) $45.1 million of favorable product volumes and mix, (ii) $4.5 million of
favorable foreign currency translation impact, (iii) $2.5 million of favorable
labor and other manufacturing costs primarily due to improved operating
efficiencies related to higher volumes and equipment investments in our plants,
(iv) a $0.7 million decrease in professional fees and (v) $0.5 million of
favorable impact from net pricing. The impact of these increases was partially
offset by: (i) $4.2 million of unfavorable inbound freight costs resulting from
both higher volumes and the continued supply chain challenges, (ii) $3.6 million
of higher employee-related, travel and other controllable costs, (iii) $2.6
million of higher materials costs primarily driven by continued inflationary
pressures experienced during the year ended December 31, 2021, (iv) $1.7 million
of higher research and development costs and (v) $0.6 million of higher
marketing and commissions costs attributable primarily to increased sales.

Adjusted Operating EBITDA in the APAC segment for the year ended December 31,
2021 increased by $9.5 million, or 30.4%. This increase was primarily driven by:
(i) $7.9 million of favorable product volumes and mix, (ii) $1.9 million of
favorable foreign currency translation impact, (iii) $1.3 million of favorable
impact from net pricing, (iv) $1.3 million lower research and development costs,
(v) $0.8 million of favorable labor and other manufacturing costs primarily due
to improved operating efficiencies related to higher volumes and equipment
investments in our plants, (vi) $0.7 million of lower material costs and (vii)
$0.7 million of lower marketing and commissions costs. These increases were
partially offset by: (i) $4.4 million of higher employee-related, travel and
other controllable costs, (ii) $0.6 million of increased tariffs and (iii) $0.4
million of unfavorable inbound freight costs resulting from both higher volumes
and the continued supply chain challenges.

Corporate and unallocated expenses reflect certain corporate-level expenses and
eliminations, which are not allocated to the segments. For the year ended
December 31, 2021, corporate and unallocated costs increased by $9.7 million, or
15.6%, compared to the same period of the prior year. This increase was
primarily driven by $11.7 million of increased employee-related expenses,
including higher incentives resulting from improved operating results, and
increased stock compensation expense resulting from an increase in the expected
achievement percentage for certain tranches of our performance share units.
These decreases were partially offset by a $3.1 million decrease in professional
fees.

Analysis of Non-Operating Income Statement Items



For the year ended December 31, 2021, "Interest expense" was $74.9 million, a
$6.5 million decrease as compared to the prior year, primarily driven by a
decrease in the average borrowings outstanding and an overall decrease in the
weighted average interest rate of outstanding debt resulting from a decrease in
LIBOR during the year ended December 31, 2021.

For the year ended December 31, 2021, "Other (income) expense - net" was an
expense of $7.5 million, compared to income of $4.6 million in the prior year.
The decrease in income of $12.1 million is primarily the result of higher net
foreign currency losses compared to 2020.
                                      -41-
--------------------------------------------------------------------------------

Analysis of Income Taxes



"Income tax (benefit) expense" for the year ended December 31, 2021 was an
expense of $28.9 million, which was a change of $35.2 million as compared to a
benefit of $6.3 million in the prior year. This increase was primarily driven by
our increase in earnings and relative weighting of jurisdictional income.

For the year ended December 31, 2021, our effective tax rate was 29.1%, compared
to an effective tax rate of 46.0% for the prior year. The decrease in effective
tax rate for the year ended December 31, 2021 was primarily the result of a
decrease in income tax benefit of 51.4% for CARES Act net operating loss
carryback provisions, and 8.3% for manufacturing and research incentive credits.
These decreases were partially offset by 19.0% of income tax expense percentage
changes for unrecognized tax benefits related to the Tax Act regulations, 11.8%
for U.S. permanent adjustments - Non Tax Act and 11.2% for taxes on foreign
income.

For the year ended December 31, 2021, the effective tax rate varied from the
21.0% statutory rate primarily due to the result of a 4.6% increase for taxes on
foreign income, 3.0% for Non Tax Act U.S. permanent adjustments, and 1.8% for
Global Intangible Low-Taxed Income. These increases were partially offset by a
1.2% decrease for the manufacturing and research incentives and a decrease of
1.1% for Foreign Derived Intangible Income. For the year ended December 31,
2020, the effective tax rate varied from the 21.0% statutory rate primarily due
to the result of a 51.2% increase for the CARES Act net operating loss carryback
provisions, a 7.1% increase for manufacturing and research incentive credits and
a 1.5% increase resulting from the adjustment of valuation allowances. These
increases were partially offset by a 19.1% decrease for the unrecognized tax
benefits and a decrease of 6.6% impact for income earned in foreign
jurisdictions.

As of December 31, 2021, we have determined that a valuation allowance is not
required for the deferred tax asset associated with the U.S. interest expense.
We may adjust the deferred tax asset valuation allowances based on possible
sources of taxable income that may be available to realize a tax benefit for
deferred tax assets. As facts and circumstances change, we may adjust our
deferred tax asset valuation allowances accordingly. Such changes in the
deferred tax asset valuation allowances will be reflected in current operations
through our income tax provision and could have a material effect on our
operating results.

                                      -42-
--------------------------------------------------------------------------------

Liquidity and Capital Resources

Overview of Factors Affecting our Liquidity



We manage cash centrally, generally reinvest net earnings locally and meet our
working capital requirements from cash and cash equivalents, cash flows from
operations and capacity under our existing credit facilities. As of December 31,
2021, our total liquidity was $407.6 million, consisting of $134.2 million of
cash and cash equivalents and $273.4 million available for additional borrowings
under our senior secured revolving credit facility ("Revolving Credit
Facility"), to the extent our compliance with financial covenants permits such
borrowings. This compares to total liquidity of $375.0 million as of
December 31, 2020. On an annual basis, our liquidity generally decreases in the
first quarter and increases in the remaining quarters of each calendar year
driven by our earnings cycle as well as the timing of large cash disbursements
made in the first quarter such as annual rebates, incentive compensation and the
build-up of inventory in advance of our historically higher sales period in the
spring and early summer months. Although our liquidity at December 31, 2021 is
consistent with historical year end levels, the components and timing of our
liquidity during the current year has been impacted by the effects of the
COVID-19 pandemic on our business.

At December 31, 2021, approximately 97% of our cash and cash equivalents were
held outside of the U.S. The majority of the cash generated in the U.S. is used
to fund current and expected future working capital requirements and to fund
debt service obligations. We maintain significant operations outside of the
U.S., and as a result, a significant portion of our cash is denominated in
foreign currencies. We manage our worldwide cash requirements by reviewing
available funds among our subsidiaries through which we conduct our business and
the cost effectiveness with which those funds can be accessed. Where
local restrictions prevent an efficient intercompany transfer of funds, our
intent is to maintain cash balances outside of the U.S. and to meet our
liquidity needs through ongoing cash flows, external borrowings, or both. We
plan to continue reinvesting foreign earnings indefinitely outside of the U.S
with certain limited exceptions.

Our future cash needs are currently expected to be primarily related to
operating activities, inclusive of capital investments, working capital and debt
service. We estimate that our capital expenditures will be between $25.0 million
and $30.0 million for the year ending December 31, 2022. The amount of actual
capital expenditures may be impacted by general economic, financial or
operational changes, including the future impact of the COVID-19 pandemic on our
operating results, the success and timing of the closing of the merger with Ali
Group, the anticipated Ice Divestiture, and competitive, legislative and
regulatory factors, among other considerations. In response to the COVID-19
pandemic throughout 2020 and the first half of 2021, we implemented contingency
plans for our operations and took what we believe were appropriate steps to
reduce operating expenses and capital spending, including reductions in the size
of our workforce and the temporary furlough of employees during 2020. We expect
that our future cash generated from operations, together with our capacity under
our existing senior secured revolving credit facility and our access to capital
markets, will provide adequate resources to meet our working capital needs and
cash requirements for at least the next 12 months.

We expect that the challenges in the supply chain and shipping and logistics
delays will likely have a continued impact on our liquidity throughout fiscal
2022, but are not aware of any known trends, demands, commitments, events or
uncertainties that will result in or that are reasonably likely to result in a
material increase or decrease in our liquidity.

Our access to, and the availability of, financing on acceptable terms in the
future may be affected by many factors, including overall liquidity in the
financial and capital markets, the state of the economy and our credit rating.
The ongoing COVID-19 pandemic, which has continued to cause volatility in the
capital markets, could also impact our ability to pursue additional financing
opportunities in the future. Moreover, we are unable to quantify the severity or
duration of the impact of the COVID-19 pandemic on our operational and financial
performance, which could have an adverse impact on our results of operations,
cash flows and financial position, potentially resulting in a default or an
acceleration of indebtedness, and could otherwise negatively impact our
liquidity and ability to make additional borrowings under our Revolving Credit
Facility.

                                      -43-
--------------------------------------------------------------------------------

Sources and Uses of Cash



Cash and cash equivalents and restricted cash as of December 31, 2021 totaled
$134.7 million, an increase of $9.3 million from the December 31, 2020 balance
of $125.4 million.

The table below summarizes our consolidated cash flows:



                                                                            Year Ended December 31,
(in millions)                                                               2021                2020
Cash provided by (used in):
Operating activities                                                   $       56.1          $   15.0
Investing activities                                                          (25.9)            (24.2)
Financing activities                                                          (21.4)             (1.3)
Effect of exchange rate changes on cash                                         0.5               5.2
Net increase (decrease) in cash and cash equivalents and
restricted cash                                                        $        9.3          $   (5.3)



Operating Activities

Cash provided by operating activities for the year ended December 31, 2021 was
$56.1 million, consisting primarily of net income of $70.3 million, which
included non-cash charges of $74.5 million for depreciation and amortization
expense, amortization of debt issuance costs, stock-based compensation and
deferred income taxes and net cash inflows of $43.4 million related primarily to
an increase in accrued rebates, accrued commissions, employee bonuses and
customer deposits all resulting from the improvement in our operating results
and net cash inflows of $42.9 million related to an increase in trade accounts
payable. These inflows were partially offset by a $116.2 million use of cash
related to an increase in inventory, $57.9 million use of cash related to a net
increase in accounts receivable and a $1.3 million net cash outflow related to
an increase in other assets.

Cash provided by operating activities for the year ended December 31, 2020 was
$15.0 million, consisting primarily of a net loss of $7.4 million, additional
non-cash charges included in the net loss of $72.1 million for depreciation and
amortization expense, amortization of debt issuance costs and stock-based
compensation, a change in deferred income taxes of $8.2 million and an $11.1
million non-cash impairment charge on trademarks in the EMEA segment.
Additionally, there were cash inflows of $21.8 million from a net decrease in
accounts receivable and $10.2 million related to a decrease in inventory balance
during the year, a $16.9 million increase in our current income tax receivable
primarily associated with CARES Act net operating loss carryback provisions,
partially offset by a $15.4 million use of cash for rebate payments to
customers, a $10.4 million use of cash for the settlement of restructuring
activities and $7.5 million of net cash used for professional fees, consisting
primarily of third-party consulting costs incurred in connection with our
Transformation Program and $34.9 million of cash outflows associated with the
timing of other current and long-term liabilities, other assets and trade
accounts payable.

Investing Activities

Cash used in investing activities of $25.9 million for the year ended December 31, 2021 was the result of capital expenditures made during the period.



Cash used in investing activities of $24.2 million for the year ended
December 31, 2020 consisted of capital expenditures of $20.1 million, largely
related to improvements of machinery and equipment within our manufacturing
plants in conjunction with our Transformation Program and $3.9 million of
payments, net of interest received, made in connection with the maturity of our
cross-currency swap in March 2020.

Financing Activities



Cash used in financing activities for the year ended December 31, 2021 was $21.4
million, consisting primarily of $24.2 million of net payments on long-term debt
and finance leases partially offset by $2.8 million of net cash received related
to the exercise of stock options.

Cash used in financing activities for the year ended December 31, 2021 was $1.3
million, consisting primarily of $2.1 million of capitalized costs incurred in
connection with the April 2020 amendment to our 2016 Credit Facility, offset by
net borrowings on long-term debt and finance leases of $0.4 million and $0.4
million of net cash received related to the exercise of stock options.

Financing Resources



Our primary financing resources consist of our 2016 Credit Agreement and our
9.50% Senior Notes due 2024. Collectively, these arrangements represent the
majority of our financing resources, which combined with cash generated by our
business operations, are used to meet our financial obligations and liquidity
requirements. The general terms of our financing arrangements as of December 31,
2021 are set forth below.

                                      -44-
--------------------------------------------------------------------------------

2016 Credit Agreement



Our 2016 Credit Agreement provides for a $1,300.0 million Senior Secured Credit
Facility consisting of (i) a senior secured Term Loan B Facility for $900.0
million and (ii) a Senior Secured Revolving Credit Facility with aggregate
commitments of $400.0 million. The maturities of the Term Loan B Facility and
Senior Secured Revolving Credit Facility are October 2025 and October 2023,
respectively.

In April of 2020, we entered into Amendment No. 7 (the "Amendment") to the 2016
Credit Agreement, to amend the financial covenants of the Revolving Credit
Facility. The terms of the Amendment, among others as set forth in the
Amendment, (i) suspend the Consolidated Total Leverage Ratio and Consolidated
Interest Coverage Ratio covenants, in each case, as defined in the 2016 Credit
Agreement, for four fiscal quarters until March 31, 2021 ("Suspension Period")
and (ii) temporarily replace the suspended covenants with a Minimum Consolidated
EBITDA covenant and a Maximum Capital Expenditure covenant, each computed on a
trailing four quarters basis and measured quarterly, and a Minimum Liquidity
covenant that is measured monthly, each as defined in the Amendment, throughout
the Suspension Period, with the Minimum Liquidity covenant extended through June
30, 2021.

Beginning in the second quarter of 2021, the Consolidated Total Leverage Ratio
and Consolidated Interest Coverage Ratio covenants were reinstated at modified
levels as compared to the covenants in effect beginning June 30, 2020 and
phased-in to the pre-amendment covenant levels in the fourth quarter of 2021.

In October 2021, we entered into a Suspension of Rights Agreement to the 2016
Credit Agreement, effective December 31, 2021, which: (i) suspends our ability
to execute non-USD currency draws under the Revolving Facility, (ii) requires
all outstanding non-USD currency loans to be repaid on or before December 31,
2021 and (iii) eliminates the option to select an interest period of 2 months
for any borrowings in USD without the lenders' consent. We do not expect that
the execution of this agreement will have a material impact on the our future
liquidity or consolidated results of operations.

As of December 31, 2021, borrowings under the 2016 Credit Agreement bore
interest at a rate per annum equal to, at our option, either (i) London
Inter-bank Offered Rate ("LIBOR") plus an applicable margin of 2.50% for the
Term Loan B Facility and 1.50% to 2.50%, for the Revolving Credit Facility
(depending on our Consolidated Total Leverage Ratio) or (ii) an alternate base
rate plus an applicable margin that is 1.00% less than the LIBOR-based
applicable margin. The Amendment includes a quarterly fee that was applicable
through the fourth quarter of 2021 in an amount equal to a per annum rate of
0.50% on the average outstanding balance of the Revolving Credit Facility,
payable on a quarterly basis.

Senior Notes



On February 18, 2016, we issued 9.50% Senior Notes due 2024 (the "Senior Notes")
in an aggregate principal amount of $425.0 million, all of which was outstanding
as of December 31, 2021. The Senior Notes were issued under an indenture with
Wells Fargo Bank, National Association, as trustee, and are fully and
unconditionally guaranteed, jointly and severally, on an unsecured basis by each
of our domestic restricted subsidiaries that is a borrower or guarantor under
the 2016 Credit Agreement.

Covenant Compliance

The 2016 Credit Agreement and indenture governing the Senior Secured Credit
Facility contains limitations on our ability to effect mergers and change of
control events as well as certain other limitations, including limitations on:
(i) the declaration and payment of dividends or other restricted payments, (ii)
incurrence of additional indebtedness or issuing preferred stock, (iii) the
creation or existence of certain liens, (iv) incurrence of restrictions on the
ability of certain of our subsidiaries to pay dividends or other payments, (v)
transactions with affiliates and (vi) sales of assets.

We were in compliance with all affirmative and negative covenants, including any
financial covenants, pertaining to our financing arrangements, in effect as of
December 31, 2021.

A summary of our outstanding financing obligations, excluding finance leases, is
as follows:

                                                    December 31,
               (in millions)                         2021                   2020

               Revolving Credit Facility        $       120.0            $   143.0
               Term Loan B Facility                     855.0                855.0
               9.50% Senior Notes due 2024              425.0                425.0

               Total debt                       $     1,400.0            $ 1,423.0



                                      -45-

--------------------------------------------------------------------------------

Summarized Guarantor Financial Information

In March 2020, the Securities and Exchange Commission adopted amendments to Rule 3-10 of Regulation S-X and created Rule 13-01 to simplify disclosure requirements related to certain registered securities, and such amendments became effective on January 4, 2021, as included below.



As discussed above, and in Note 8, "Debt", of the Consolidated Financial
Statements included in Part II, Item 8 of this Annual Report on Form 10-K, in
February 2016, we issued Senior Notes under an indenture with Wells Fargo Bank,
National Association, as trustee (the "Trustee"). The Senior Notes were
initially sold to qualified institutional buyers pursuant to Rule 144A (and
outside the U.S. in reliance on Regulation S) under the Securities Act of 1933
("Securities Act"). In September 2016, we completed an exchange offer pursuant
to which all of the initial Senior Notes were exchanged for new Senior Notes,
the issuance of which was registered under the Securities Act.

The Senior Notes are fully and unconditionally guaranteed, jointly and
severally, on an unsecured basis by each of our domestic restricted subsidiaries
that is a borrower or guarantor under the Senior Secured Credit Facilities,
discussed above. The Senior Notes and the subsidiary guarantees are unsecured,
senior obligations.

We must generally offer to repurchase all the outstanding Senior Notes upon the
occurrence of certain specific change of control events at a purchase price
equal to 101.0% of the principal amount of Senior Notes purchased plus accrued
and unpaid interest to the date of purchase. The indenture provides for
customary events of default. Generally, if an event of default occurs (subject
to certain exceptions), the Trustee or the holders of at least 25% in aggregate
principal amount of the then-outstanding Senior Notes may declare all the Senior
Notes to be due and payable immediately.

The indenture governing the Senior Notes contains limitations on our ability to
effect mergers and change of control events as well as other limitations,
including limitations on: the declaration and payment of dividends or other
restricted payments; incurring additional indebtedness or issuing preferred
stock; the creation or existence of certain liens; incurring restrictions on the
ability of certain of our subsidiaries to pay dividends or other payments;
transactions with affiliates; and sales of assets.

Effective February 15, 2022, the Senior Notes are redeemable, at our option, in
whole or in part from time to time, at a redemption price equal to 100.0% of the
principal amount.

In accordance with Rule 3-10 of Regulation S-X, the following tables present
consolidating financial information for (a) Welbilt ("Parent"); (b) the
guarantors of the Senior Notes, which include substantially all of the domestic,
100% owned subsidiaries of Welbilt ("Guarantor Subsidiaries"); and (c) the
wholly-owned foreign subsidiaries of Welbilt, which do not guarantee the Senior
Notes ("Non-Guarantor Subsidiaries").

The financial information of the Guarantor Subsidiaries in the following table
is presented on a combined basis with intercompany balances and transactions
between the entities within the Guarantor Subsidiaries eliminated. The
information also includes elimination entries necessary to consolidate the
Guarantor Subsidiaries and the Non-Guarantor Subsidiaries. Investments in
subsidiaries are accounted for using the equity method of accounting. The
principal elimination entries eliminate investments in subsidiaries, equity and
intercompany balances and transactions. Separate financial statements of the
Guarantor Subsidiaries are not presented because as guarantors, these
subsidiaries are fully and unconditionally, jointly and severally liable under
the guarantees, except for normal and customary release provisions.

As discussed in Note 20, "Business Segments" of the Consolidated Financial
Statements included in Part II, Item 8 of this Annual Report on Form 10-K, we
revised the allocation of certain of our functional expenses between the
corporate-level and the geographic business segments during the first quarter of
2020. The impacts of the revised allocation predominantly impacts the Parent and
Guarantor Subsidiaries financial information included in the tables below and
these changes did not impact our previously reported consolidated financial
results.

                                      -46-
--------------------------------------------------------------------------------



                                 WELBILT, INC.
                     Consolidating Statement of Operations
                      For the year ended December 31, 2021

                                                                                           Non-
                                                                 Guarantor              Guarantor              Consolidating

(in millions)                                  Parent           Subsidiaries           Subsidiaries             Adjustments             Consolidated
Net sales                                    $     -          $     1,088.7          $       963.9          $         (505.7)         $     1,546.9
Cost of sales                                      -                  827.8                  665.2                    (505.7)                 987.3
Gross profit                                       -                  260.9                  298.7                         -                  559.6
Selling, general and administrative
expenses                                        87.7                  133.3                  116.6                         -                  337.6
Amortization expense                               -                   28.2                   11.2                         -                   39.4

Restructuring and other (recovery)
expense                                         (0.1)                  (0.1)                   0.8                         -                    

0.6


Loss from impairment and disposal of
assets - net                                     0.1                    0.2                    0.1                         -                    0.4
(Loss) earnings from operations                (87.7)                  99.3                  170.0                         -                  181.6
Interest expense                                74.4                    0.5                      -                         -                   74.9

Other (income) expense - net                  (155.6)                 (16.2)                  31.8                     147.5                    7.5
Equity in earnings of subsidiaries             207.2                  109.1                      -                    (316.3)                     -
Earnings before income taxes                   200.7                  224.1                  138.2                    (463.8)                  99.2
Income tax (benefit) expense                   (17.2)                  17.0                   29.1                         -                   28.9
Net earnings                                 $ 217.9          $       207.1          $       109.1          $         (463.8)         $        70.3
Total other comprehensive loss, net of
tax                                             (5.0)                  (6.5)                (173.7)                    180.1                   (5.1)
Comprehensive income (loss)                  $ 212.9          $       200.6          $       (64.6)         $         (283.7)         $        65.2





                                      -47-

--------------------------------------------------------------------------------


                                 WELBILT, INC.
                          Consolidating Balance Sheet
                            As of December 31, 2021

                                                                                            Non-
                                                                  Guarantor              Guarantor             Consolidating
(in millions)                                  Parent            Subsidiaries           Subsidiaries            Adjustments             Consolidated
Assets
Current assets:
Cash and cash equivalents                   $     1.8          $         2.2          $       130.2          $             -          $       134.2
Restricted cash                                     -                      -                    0.5                        -                    0.5

Accounts receivable - net                         0.4                  108.1                  112.0                        -                  220.5

Inventories - net                                   -                  163.4                  131.0                        -                  294.4
Prepaids and other current assets                27.0                   10.4                   21.1                        -                   58.5

Total current assets                             29.2                  284.1                  394.8                        -                  708.1
Property, plant and equipment - net              14.7                   68.0                   52.9                        -                  135.6
Operating lease right-of-use assets               1.9                    5.1                   37.2                        -                   44.2
Goodwill                                            -                  832.4                  103.9                        -                  

936.3


Other intangible assets - net                     0.2                  287.6                  133.0                        -                  420.8

Due from affiliates                                 -                3,561.5                      -                 (3,561.5)                     -
Investment in subsidiaries                    4,694.5                      -                      -                 (4,694.5)                     -
Other non-current assets                          8.6                    4.2                   19.8                        -                   32.6
Total assets                                $ 4,749.1          $     5,042.9          $       741.6          $      (8,256.0)         $     2,277.6
Liabilities and equity
Current liabilities:
Trade accounts payable                      $       -          $        64.1          $        66.5          $             -          $       130.6
Accrued expenses and other
liabilities                                      32.8                   93.5                   84.4                        -                  210.7
Current portion of long-term debt and
finance leases                                      -                    0.5                    0.4                        -                    0.9

Product warranties                                  -                   19.6                   11.3                        -                   30.9

Total current liabilities                        32.8                  177.7                  162.6                        -                  373.1
Long-term debt and finance leases             1,387.5                      -                    0.5                        -                1,388.0
Deferred income taxes                            37.6                      -                   26.6                        -                   64.2
Pension and postretirement health
liabilities                                       9.3                    8.5                    3.9                        -                   21.7

Due to affiliates                             2,910.7                      -                  650.9                 (3,561.6)                     -
Investment in subsidiaries                          -                  143.6                      -                   (143.6)                     -
Operating lease liabilities                       1.7                    3.5                   30.1                        -                   35.3
Other long-term liabilities                      11.2                   15.1                   10.6                        -                   36.9
Total non-current liabilities                 4,358.0                  170.7                  722.6                 (3,705.2)               1,546.1

Total equity (deficit)                          358.3                4,694.5                 (143.6)                (4,550.8)                 

358.4


Total liabilities and equity                $ 4,749.1          $     5,042.9          $       741.6          $      (8,256.0)         $     2,277.6



Leasing Arrangements

We lease various assets under leasing arrangements. The future estimated
payments under these arrangements are disclosed in Note 16, "Leases", of the
Notes to the Consolidated Financial Statements included in Part II, Item 8 of
this Annual Report on Form 10-K.

                                      -48-
--------------------------------------------------------------------------------

Contractual Obligations



The following table summarizes our significant contractual obligations as of
December 31, 2021:

(in millions)                      Total              2022             2023             2024             2025            2026            Thereafter
Long-term debt                  $ 1,400.0          $     -          $ 120.0          $ 434.0          $ 846.0          $    -          $         -
Interest obligations                227.1             63.0             63.0             62.9             38.2               -                    -
Finance leases                        1.6              1.0              0.3              0.2              0.1               -                    -
Operating lease
liabilities                          44.4              9.0              7.8              6.5              4.8             3.4                 12.9
Income taxes payable                  6.7              6.6                -                -                -             0.1                    -
Purchase obligations                141.7            122.6             18.0              0.7              0.2             0.1                  0.1
Total contractual
obligations                     $ 1,821.5          $ 202.2          $ 209.1          $ 504.3          $ 889.3          $  3.6          $      13.0



Unrecognized tax benefits totaling $8.1 million as of December 31, 2021
excluding related interests and penalties, are not included in the table above
because the timing of their resolution cannot be estimated. See Note 7, "Income
Taxes", of the Notes to the Consolidated Financial Statements included in Part
II, Item 8 of this Annual Report on Form 10-K for disclosures surrounding
uncertain income tax positions.

We maintain defined benefit plans for certain of our operations in the Americas
and EMEA regions. During the year ended December 31, 2021, cash contributions to
all of our defined benefit plans were $7.5 million and we estimate that our
defined benefit plan contributions will be approximately $6.9 million for the
year ending December 31, 2022. See Note 13, "Employee Benefit Plans", of the
Notes to the Consolidated Financial Statements included in Part II, Item 8 of
this Annual Report on Form 10-K for further discussion.

See Note 11, "Contingencies and Significant Estimates", of the Notes to the
Consolidated Financial Statements included in Part II, Item 8 of this Annual
Report on Form 10-K for disclosures regarding our environmental, health, safety,
contingencies and other matters.


Non-GAAP Financial Measures



We use certain non-GAAP financial measures discussed below to evaluate our
results of operations, financial condition and liquidity. We believe that the
presentation of these non-GAAP financial measures, when viewed as a supplement
to our results prepared in accordance with U.S. GAAP, provides useful
information to investors in evaluating the ongoing performance of our operating
businesses, provides greater transparency into our results of operations and is
consistent with how we evaluate our operating performance and liquidity. In
addition, these non-GAAP measures address questions we routinely receive from
analysts and investors and, in order to ensure that all investors have access to
similar data, we make this data available to the public. None of the non-GAAP
measures presented should be considered as an alternative to net earnings,
earnings from operations, net cash used in operating activities, net sales or
any other measures derived in accordance with U.S. GAAP. These non-GAAP measures
have important limitations as analytical tools and should not be considered in
isolation or as substitutes for financial measures presented in accordance with
U.S. GAAP. The presentation of our non-GAAP financial measures may change from
time to time, including as a result of changed business conditions, new
accounting rules or otherwise. Further, our use of these terms may vary from the
use of similarly-titled measures by other companies due to the potential
inconsistencies in the method of calculation and differences due to items
subject to interpretation.

Free Cash Flow



We refer to "Free Cash Flow", a non-GAAP measure, as our net cash provided by or
used in operating activities less capital expenditures plus cash receipts on our
beneficial interest in sold receivables and the related impact of terminating
our accounts receivable securitization program during the first quarter of 2019.
We believe this non-GAAP financial measure is useful to investors in measuring
our ability to generate cash internally to fund our debt repayments,
acquisitions, dividends and share repurchases, if any. Free Cash Flow reconciles
to net cash used in operating activities included in our Consolidated Statements
of Cash Flows presented in accordance with U.S. GAAP, as follows:

                                                                           Year Ended December 31,
(in millions)                                                      2021               2020              2019
Net cash provided by (used in) operating activities           $    56.1            $   15.0          $ (269.7)
Capital expenditures                                              (25.9)              (20.1)            (33.9)
Cash receipts on beneficial interest in sold
receivables (1)                                                       -                   -             280.7
Termination of accounts receivable securitization
program (2)                                                           -                   -              96.9
Free Cash Flow                                                $    30.2            $   (5.1)         $   74.0

(1) Represents the cash receipts from the beneficial interest on sold receivables within the accounts receivable securitization program and were classified as "Cash flows from investing activities" in the Consolidated Statements of Cash Flows through final settlement of the program in the second quarter of 2019.


                                      -49-
--------------------------------------------------------------------------------

(2) Represents the increase in accounts receivable resulting from the
termination of the accounts receivable securitization program during the first
quarter of 2019, which is reflected in "Cash flows from operating activities" in
the Consolidated Statements of Cash Flows.


Adjusted Operating EBITDA



In addition to analyzing our operating results on a U.S. GAAP basis, we also
review our results on an "Adjusted Operating EBITDA" basis. Adjusted Operating
EBITDA is defined as net earnings before interest expense, income taxes, other
income or expense, depreciation and amortization expense plus certain other
items such as loss from impairment of assets, gain or loss from disposal of
assets, restructuring activities, loss on modification or extinguishment of
debt, acquisition-related transaction and integration costs, Transformation
Program expense, separation expense and certain other items, which are
non-operating and unusual in nature. We use Adjusted Operating EBITDA as the
basis on which we evaluate our financial performance and make resource
allocations and other operating decisions. We consider it important that
investors review the same operating information used by us. Our Adjusted
Operating EBITDA reconciles to net (loss) earnings as presented in the
Consolidated Statements of Operations in accordance with U.S. GAAP as follows:

                                                                           Year Ended December 31,
(in millions, except percentage data)                             2021              2020              2019
Net earnings (loss)                                            $   70.3          $   (7.4)         $   55.9
Income tax expense (benefit)                                       28.9              (6.3)             19.8
Other expense (income) - net                                        7.5              (4.6)              0.9

Interest expense                                                   74.9              81.4              97.3
Earnings from operations                                          181.6              63.1             173.9

Loss from impairment and loss on disposal of assets - net

                                                                 0.4              11.6               0.7
Restructuring activities (1)                                        1.4               8.2               9.8

Amortization expense                                               40.9              40.6              39.8
Depreciation expense                                               22.2              20.7              21.1
Transformation Program expense (2)                                  4.6              23.3              35.3
Transaction costs (3)                                              26.4               0.2               1.1
Other items (4)                                                    (2.1)              3.2               4.5
Total Adjusted Operating EBITDA                                $  275.4

$ 170.9 $ 286.2



Adjusted Operating EBITDA margin (5)                               17.8  %           14.8  %           18.0  %


(1) Restructuring activities include costs associated with actions to improve
operating efficiencies and rationalization of our cost structure. Refer to Note
14, "Business Transformation Program and Restructuring" for discussion of the
impact to the Consolidated Statements of Operations.

(2) Transformation Program expense includes consulting and other costs
associated with executing our Transformation Program initiatives. Refer to Note
14, "Business Transformation Program and Restructuring" for discussion of the
impact to the Consolidated Statements of Operations.

(3) Transaction costs are associated with acquisition and integrated-related
activities. Transaction costs for the year ended December 31, 2021 are related
to the pending sale of the Company and consist primarily of professional
services recorded in "Selling, general and administrative expenses." Transaction
costs recorded in "Cost of sales" include $0.1 million related to inventory fair
value purchase accounting adjustments for the year ended December 31, 2019.
Professional services and other direct acquisition and integration costs
recorded in "Selling, general and administrative expenses" were $0.2 million and
$1.0 million, for the years ended December 31, 2020 and 2019, respectively.

(4) Other items are costs which are not representative of our operational
performance. For the year ended December 31, 2021, other items consist primarily
of a partial recovery of $2.0 million from the diversion of funds in 2018 from
one of our Company's EMEA locations and is included in "Selling, general and
administrative expenses" in the Consolidated Statements of Operations. For the
year ended December 31, 2020, other items includes an expense of $3.1 million
for amounts due for customs duties, fees and interest on previously imported
products, which are included in "Restructuring and other expense" in the
Consolidated Statements of Operations and $0.1 million of professional fees for
recovery of misappropriated funds within the Crem business related to the 2018
matter. Refer to Note 13, "Contingencies and Significant Estimates" for
discussion of the impact on the Consolidated Statements of Operations. For the
year ended December 31, 2019, the amount includes certain costs related to
concluded litigation and other professional fees. Unless otherwise noted, all
such amounts are included within "Selling, general and administrative expenses"
in the Consolidated Statements of Operations.

(5) Adjusted Operating EBITDA margin is calculated by dividing the dollar amount of Adjusted Operating EBITDA by net sales.


                                      -50-
--------------------------------------------------------------------------------

Adjusted Diluted Net Earnings and Adjusted Diluted Net Earnings Per Share




We define Adjusted Diluted Net Earnings as net earnings before the impact of
certain items, such as loss on modification or extinguishment of debt, loss from
impairment of assets, gain or loss from disposal of assets, restructuring
activities, separation expense, Transformation Program expense,
acquisition-related transaction and integration costs, certain other items,
expenses associated with pension settlements, foreign currency transaction gain
or loss, the Tax Act and the tax effect of the aforementioned adjustments, as
applicable. Adjusted Diluted Net Earnings Per Share for each period represents
Adjusted Net Earnings while giving effect to all potentially dilutive shares of
common stock that were outstanding during the period. We believe these measures
are useful to investors in assessing the ongoing performance of our underlying
businesses before the impact of certain items which are non-operating and
unusual in nature. The following table presents Adjusted Diluted Net Earnings
and Adjusted Diluted Net Earnings Per Share reconciled to net earnings and
diluted net earnings per share, respectively, presented in accordance with U.S.
GAAP:

                                                                             Year Ended December 31,
(in millions, except per share data)                                2021                2020              2019
Net earnings (loss)                                            $    70.3

$ (7.4) $ 55.9

Loss from impairment and loss on disposal of assets - net

                                                                  0.4                 11.6               0.7
Restructuring activities (1)                                         1.4                  8.2               9.8

Transformation Program expense (2)                                   4.6                 23.3              35.3
Transaction costs (3)                                               26.4                  0.2               1.1
Other items (4)                                                     (2.1)                 3.2               4.5
Pension settlement (5)                                                 -                    -               1.2
Foreign currency transaction loss (gain) (6)                         6.0                 (5.7)              0.7

Tax effect of adjustments (7)                                       (8.5)               (10.3)            (12.9)
Total Adjusted Net Earnings                                    $    98.5

$ 23.1 $ 96.3



Per Share Basis
Diluted net earnings (loss)                                    $    0.49

$ (0.05) $ 0.39

Loss from impairment and loss on disposal of assets - net

                                                                 0.01                 0.08              0.01
Restructuring activities (1)                                        0.01                 0.06              0.07

Transformation Program expense (2)                                  0.03                 0.16              0.25
Transaction costs (3)                                               0.18                    -              0.01
Other items (4)                                                    (0.01)                0.02              0.03
Pension settlement (5)                                                 -                    -              0.01
Foreign currency transaction loss (gain) (6)                        0.04                (0.04)                -

Tax effect of adjustments (7)                                      (0.06)               (0.07)            (0.09)
Total Adjusted Diluted Net Earnings                            $    0.69

$ 0.16 $ 0.68




(1) Restructuring activities include costs associated with actions to improve
operating efficiencies and rationalization of our cost structure. Refer to Note
14, "Business Transformation Program and Restructuring" for discussion of the
impact to the Consolidated Statements of Operations.

(2) Transformation Program expense includes consulting and other costs
associated with executing our Transformation Program initiatives. Refer to Note
14, "Business Transformation Program and Restructuring" for discussion of the
impact to the Consolidated Statements of Operations.

(3) Transaction costs are associated with acquisition and integrated-related
activities. Transaction costs for the year ended December 31, 2021 are related
to the pending sale of the Company and consist primarily of professional
services recorded in "Selling, general and administrative expenses." Transaction
costs recorded in "Cost of sales" include $0.1 million related to inventory fair
value purchase accounting adjustments for the year ended December 31, 2019.
Professional services and other direct acquisition and integration costs
recorded in "Selling, general and administrative expenses" were $0.2 million and
$1.0 million, for the years ended December 31, 2020 and 2019, respectively.

(4) Other items are costs which are not representative of our operational
performance. For the year ended December 31, 2021, other items consist primarily
of a partial recovery of $2.0 million from the diversion of funds in 2018 from
one of our Company's EMEA locations and is included in "Selling, general and
administrative expenses" in the Consolidated Statements of Operations. For the
year ended December 31, 2020, other items includes an expense of $3.1 million
for amounts due for customs duties, fees and interest on previously imported
products, which are included in "Restructuring and other expense" in the
Consolidated Statements of Operations and $0.1 million of professional fees for
recovery of misappropriated funds within the Crem business related to the 2018
matter. Refer to Note 13, "Contingencies and Significant Estimates" for
discussion of the impact on the Consolidated Statements of Operations. For the
year ended December 31, 2019, the amount includes certain costs related to
concluded litigation and other professional fees. Unless otherwise noted, all
such amounts are included within "Selling, general and administrative expenses"
in the Consolidated Statements of Operations.

(5) Pension settlement represents non-cash pension losses resulting from settlement of pension obligations. Refer to Note 13, "Employee Benefit Plans" for discussion of the impact to the Consolidated Statements of Operations.



(6) Foreign currency transaction gains and losses are inclusive of gains and
losses on related foreign currency exchange contracts not designated as hedging
instruments for accounting purposes.
(7) The tax effect of adjustments is determined using the statutory tax rates
for the countries comprising such adjustments.
                                      -51-
--------------------------------------------------------------------------------

Organic Net Sales



We define "Organic net sales" as net sales before the impacts of acquisitions
and foreign currency translations during the period. We believe the Organic net
sales measure is useful to investors in assessing the ongoing performance of our
underlying businesses. Organic net sales reconcile to net sales presented in
accordance with U.S. GAAP as follows:

                                                         Year Ended December 31,
(in millions)                                      2021           2020           2019
Consolidated:
Net sales                                       $ 1,894.0      $ 1,361.7      $ 1,853.4
Less: Intersegment sales                           (347.1)        (208.3)        (259.5)
Net sales (as reported)                           1,546.9        1,153.4        1,593.9

Impact of foreign currency translation(1)           (25.2)             -              -
Organic net sales                               $ 1,521.7      $ 1,153.4      $ 1,593.9

Americas:
Net sales                                       $ 1,185.8      $   867.0      $ 1,208.4
Less: Intersegment sales                           (136.3)         (92.4)        (133.1)
Third-party net sales                             1,049.5          774.6        1,075.3

Impact of foreign currency translation(1)            (7.1)             -    

-


Total Americas organic net sales                $ 1,042.4      $   774.6      $ 1,075.3

EMEA:
Net sales                                       $   447.1      $   292.6      $   392.7
Less: Intersegment sales                           (141.9)         (69.1)         (79.5)
Third-party net sales                               305.2          223.5          313.2

Impact of foreign currency translation(1)           (13.4)             -              -
Total EMEA organic net sales                    $   291.8      $   223.5      $   313.2

APAC:
Net sales                                       $   261.1      $   202.1      $   252.3
Less: Intersegment sales                            (68.9)         (46.8)         (46.9)
Third-party net sales                               192.2          155.3          205.4

Impact of foreign currency translation(1)            (4.7)             -              -
Total APAC organic net sales                    $   187.5      $   155.3      $   205.4

(1) The impact from foreign currency translation is calculated by translating current period activity at the weighted average prior period rates.

Critical Accounting Estimates



The preparation of financial statements in conformity with U.S. GAAP requires us
to make estimates and assumptions in certain circumstances that affect amounts
reported in the consolidated financial statements and related footnotes. In
preparing these consolidated financial statements, we have made our best
estimates and judgments of certain amounts included in the consolidated
financial statements giving due consideration to materiality. However,
application of accounting estimates involves the exercise of judgment and use of
assumptions as to future uncertainties and, as a result, actual results could
differ from these estimates, particularly as it relates to forecasts and other
assumptions impacted by the uncertainties surrounding the COVID-19 pandemic. The
extent to which the economic disruptions of the COVID-19 pandemic impacts our
accounting estimates will depend on future developments, including the duration,
scope and severity of the pandemic, the actions taken to contain or mitigate its
impact in each of the countries in which we operate globally, the development
and global distribution of treatments of COVID-19 vaccines, and the timing of
the resumption of economic activity to pre-pandemic levels.

A critical accounting estimate is an estimate that (i) is made in accordance
with generally accepted accounting principles, (ii) involves a significant level
of estimation uncertainty and (iii) has had or is reasonably likely to have a
material impact on our financial condition or results of operations. Our
critical accounting estimates appear below. We also believe that our accounting
policies are important to the reader.
                                      -52-
--------------------------------------------------------------------------------

Therefore, please refer also to the Notes to Consolidated Financial Statements
included in Part II, Item 8 of this Annual Report on Form 10-K for more detailed
description of these and other accounting policies of Welbilt. We currently
disclose the impact of changes to assumptions in the applicable quarterly or
annual filings in which there is a material financial statement impact.

Revenue Recognition - Revenue is recognized based on the satisfaction of
performance obligations, which occurs when service is provided or control of a
good transfers to a customer. A majority of our net sales are recognized at the
point in time when products are shipped from our manufacturing facilities. For
the majority of foodservice equipment and aftermarket parts and support, the
transfer of control and revenue recognition materializes when the products are
shipped from the manufacturing facility or the service is provided to the
customer. We typically invoice our customers with payment terms of 30 days and
our average collection cycle is generally less than 60 days and we have
determined these payment terms do not contain a significant financing component.
Costs to obtain a customer contract are expensed as incurred as our contract
periods are generally short term in nature. The amount of consideration received
and revenue recognized varies with marketing incentives such as annual customer
rebate programs and right of return terms that are offered to customers.
Variable consideration as a result of customer rebate programs is typically
based on calendar-year purchases and is determined using the expected value
method in interim periods as prescribed in the guidance. Customers have the
right to return eligible equipment and parts. The expected returns are based on
an analysis of historical experience. The estimate of revenue is adjusted at the
earlier of when the most likely amount of the expected consideration changes or
when the consideration becomes fixed.

In recognizing revenue, we make significant judgments related to identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price, and allocating the transaction price to each performance obligation.



Income Taxes - We are subject to income taxes in the U.S. and various foreign
jurisdictions. The determination of our income tax positions involves
consideration of uncertainties, changing fiscal policies, tax laws, court
rulings, regulations and related legislation. The Tax Act, enacted on December
22, 2017, introduced comprehensive and complex tax legislation, including a
provision designed to tax global intangible low-taxed income ("GILTI"),
foreign-derived intangible income("FDII"), and other items that are subject to
continuous guidance and interpretations. The Coronavirus Aid, Relief, and
Economic Security Act ("CARES Act") was enacted on March 27, 2020 and includes
many measures intended to assist companies during the COVID-19 pandemic
including temporary changes to income and non-income-based tax laws, some of
which were enacted under the Tax Cuts and Jobs Act ("Tax Act") in 2017.
Accordingly, significant management judgment is required in determining the
provision for income taxes, deferred tax assets and liabilities, unrecognized
tax benefits, and the valuation allowance recorded against deferred tax assets.

Deferred income taxes arise from temporary differences between the tax bases of
assets and liabilities and their reported amounts in the financial statements
that will result in taxable or deductible amounts in future years when the
reported amount of the assets and liabilities are recovered or settled,
respectively. The recognition and measurement of deferred tax asset and
liability balances and the corresponding deferred tax expense are determined for
each tax-paying component in each applicable jurisdiction. We record a valuation
allowance that represents a reduction of deferred tax assets if, based on the
weight of available evidence, both positive and negative, it is
more-likely-than-not that the deferred tax assets will not be realized.

We also recognize liabilities for unrecognized tax benefits, which are
recognized if the weight of available evidence indicates that it is not
more-likely-than-not that the positions will be sustained on examination,
including resolution of the related appeals or litigation processes, if any. At
each reporting period, unrecognized tax benefits are reassessed and adjusted if
our judgment changes as a result of new information.

We adopted the period cost method for the computation of GILTI, that was introduced in the Tax Act.

We recognize interest and penalties related to unrecognized tax benefits as a component of income tax expense.



Inventories and Related Reserve for Obsolete and Excess Inventory - The majority
of our inventories are valued at the lower of cost or net realizable value using
the first-in, first-out (FIFO) method. Certain inventories are valued using the
last-in, first-out (LIFO) method. All inventories are reduced by a reserve for
excess and obsolete inventories. The estimated reserve is based upon specific
identification of excess or obsolete inventories based on historical usage,
estimated future usage, sales requiring the inventory and on historical
write-off experience, and is subject to change if actual experience
deteriorates.

Goodwill, Other Intangible Assets and Other Long-Lived Assets - We perform
annual impairment tests of goodwill and intangible assets with indefinite lives
at June 30 of each fiscal year and whenever a triggering event occurs between
annual impairment tests. Our trademarks and tradenames are classified as
indefinite-lived intangible assets as there are no regulatory, contractual,
competitive, economic or other factors which limit the useful lives of these
intangible assets. We perform the goodwill impairment test for each of our
reporting units which are the Americas, EMEA and APAC. We perform the
indefinite-lived intangible asset impairment test at the unit of account level,
which is the Americas, EMEA and APAC. When testing for impairment, we have the
option to first assess qualitative factors to determine whether it is
more-likely-than-not that the fair value of any reporting unit or indefinite
lived intangible asset is less than its carrying amount. In conducting a
qualitative assessment, we evaluate the totality of relevant events and
circumstances that affect the fair value or carrying value of the reporting unit
or asset. These events and circumstances include, but are not limited to,
macroeconomic conditions, industry and competitive environment conditions,
overall financial performance, reporting unit specific events and market
considerations. In those instances where we conclude that it is not
more-likely-than-not that the fair value is less than the carrying amount, no
impairment is indicated and no further impairment test is performed.

When we choose not to perform a qualitative assessment, or if, based on the
qualitative assessment, we conclude it is more-likely-than-not that the fair
value is less than the carrying amount, a quantitative impairment test is
performed at the reporting unit level utilizing the one-step approach. This
one-step approach identifies both the existence of impairment and the amount of
the impairment loss. In conducting the
                                      -53-
--------------------------------------------------------------------------------

quantitative analysis, we compare the fair value of the reporting unit with
goodwill or the indefinite lived intangible asset to its carrying value. The
fair value is determined using the income approach based on the present value of
expected future cash flows, including terminal value, and a weighted average
cost of capital all of which involve management judgment and assumptions. When
the carrying amount of the reporting or the intangible asset exceeds its fair
value, we recognize an impairment loss in an amount equal to the excess;
however, the impairment loss for goodwill is limited to the total amount of the
goodwill allocated to the reporting unit. See Note 5, "Goodwill and Other
Intangible Assets - Net", of the Notes to the Consolidated Financial Statements
included in Part II, Item 8 of this Annual Report on Form 10-K for further
details on our impairment assessments.

When reviewing long-lived assets, other than goodwill and other intangible
assets with indefinite lives, we group our assets and liabilities at the lowest
level for which identifiable cash flows are largely independent of the cash
flows of other assets and liabilities and evaluate the asset group against the
sum of the undiscounted future cash flows to determine impairments. If an
impairment is determined to exist, the impairment loss is calculated based upon
comparison of the fair value to the net book value of the assets.

We monitor market conditions and determine if any additional interim reviews of
goodwill, other intangibles or long-lived assets are warranted. Deterioration in
the market or actual results as compared with our projections may ultimately
result in a future impairment. In the event we determine that assets are
impaired in the future, we would need to recognize a non-cash impairment charge,
which could have a material adverse effect on our Consolidated Balance Sheets
and Consolidated Statements of Operations.

Product Warranties - In the normal course of business, we provide our customers
warranties covering workmanship, and in some cases materials, on products
manufactured by us. Such warranties generally provide that products will be free
from defects for periods typically ranging from 12 to 60 months with certain
equipment having longer-term warranties. If a product fails to comply with our
warranty, we may be obligated, at our expense, to correct any defect by
repairing or replacing such defective product. We provide for an estimate of
costs that we may incur under our warranty at the time of revenue recognition
based on historical warranty experience for the related product or estimates of
projected losses due to specific warranty issues on new products. These costs
primarily include labor and materials, as necessary, associated with repair or
replacement. The primary factors that affect our warranty liability include the
number of shipped units and historical and anticipated rates or warranty claims.
As these factors are impacted by actual experience and future expectations, we
assess the adequacy of our recorded warranty liability and adjust the amounts as
necessary.

Product Liabilities - We are subject in the normal course of business to product
liability lawsuits. To the extent permitted under applicable laws, our exposure
to losses from these lawsuits is mitigated by insurance with self-insurance
retention limits. We record product liability reserves for our self-insured
portion of any pending or threatened product liability actions. Our reserve is
based upon two estimates. First, we track the population of all outstanding
pending and threatened product liability cases to determine an appropriate case
reserve for each based upon our best judgment and the advice of legal counsel.
These estimates are continually evaluated and adjusted based upon changes to the
facts and circumstances surrounding the case. Second, we determine the amount of
additional reserve required to cover incurred but not reported product liability
issues and to account for possible adverse development of the established case
reserves. We have established a position within the actuarially determined range
that we believe is the best estimate for incurred but unreported claims. We
perform this analysis two times per year.

Stock-Based Compensation - The computation of the expense associated with
stock-based compensation requires the use of certain valuation models and is
based on projected achievement of underlying performance criteria for
performance shares. We currently use a Black-Scholes option pricing model to
calculate the fair value of our stock options. The Black-Scholes model requires
the use of assumptions regarding the volatility of our stock, the expected life
of the stock award and our dividend ratio. We primarily use historical data to
determine the assumptions to be used in the Black-Scholes model and have no
reason to believe that future data is likely to differ materially from
historical data. However, changes in the assumptions regarding future stock
price volatility, future dividend payments and future stock award exercise
experience could result in a change in the assumptions used to value awards in
the future and may result in a material change to the fair value calculation of
stock-based awards. Stock-based compensation expense is recognized only for
those stock-based awards expected to vest.

Employee Benefit Plans - We provide a range of benefits to our employees and
retired employees, including pensions and postretirement health care coverage.
We record Defined Benefit Plan assets and obligations using amounts calculated
annually as of our measurement date utilizing various actuarial assumptions such
as discount rates, expected return on plan assets, compensation increases,
retirement and mortality rates, and health care cost trend rates as of that
date. The approaches we use to determine the annual assumptions are as follows:

•Discount Rate - Our discount rate assumptions are based on the interest rate of
non-callable high-quality corporate bonds, with appropriate consideration of
demographics of the participants in our defined benefit plans and benefit
payment terms.

•Expected Return on Plan Assets - Our expected return on plan assets assumptions
are based on our expectation of the long-term average rate of return on assets
in the pension funds, which is reflective of the current and projected asset mix
of the funds and considers the historical returns earned on the funds.

•Retirement and Mortality Rates - Our retirement and mortality rate assumptions are based primarily on actual plan experience and actuarial mortality tables.



•Health Care Cost Trend Rates - Our health care cost trend rate assumptions are
developed based on historical cost data, near-term outlook and an assessment of
likely long-term trends.

                                      -54-
--------------------------------------------------------------------------------

Measurements of net periodic benefit cost are based on the assumptions used for
the previous year-end measurements of assets and obligations. We review our
actuarial assumptions on an annual basis and make modifications to the
assumptions when appropriate. As required by U.S. GAAP, the effects of the
modifications are recorded currently or amortized over future periods. We have
developed the assumptions with the assistance of our independent actuaries and
other relevant sources, and we believe that the assumptions used are reasonable;
however, changes in these assumptions could impact our financial position,
results of operations or cash flows. Refer to Note 13, "Employee Benefit Plans",
of the Notes to the Consolidated Financial Statements included in Part II, Item
8 of this Annual Report on Form 10-K for a summary of the impact of a 0.5%
change in the discount rate and rate of return on plan assets would have on our
consolidated financial statements.

Recent Accounting Changes and Pronouncements



See Note 2, "Basis of Presentation and Summary of Significant Accounting
Policies", of the Notes to the Consolidated Financial Statements included in
Part II, Item 8 of this Annual Report on Form 10-K for discussion of recently
issued accounting pronouncements applicable to us and the impact of those
standards on our consolidated financial statements and related disclosures.

                                      -55-

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses